The clinical data further revealed that HBV-related HCC patients with elevated HBx and MDM2 levels exhibited a worse OS and a shorter disease-free survival period than other patients (Figure 3g and Supplementary Table S1). This evidence concerns the gene MDM2 and hepatocellular carcinoma.